Back to Results
First PageMeta Content
Medicine / Chemistry / Brain / Sodium valproate / Valproic acid / Lamotrigine / Valproate semisodium / Epilepsy / Bipolar disorder / Anticonvulsants / Mood stabilizers / Teratogens


CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls
Add to Reading List

Document Date: 2015-01-29 07:33:53

Open Document

File Size: 85,66 KB

Share Result on Facebook

City

London / /

Company

Micropakine L.P. / /

Country

Norway / Iceland / United Kingdom / /

/

Facility

Canary Wharf / /

IndustryTerm

healthcare professionals / dear healthcare professional letter / prevention of migraine / treatment for migraine / migraine prevention / treatment of epilepsy / /

MedicalCondition

Autism spectrum disorders / childhood autism / neural tube defects / migraine / autistic spectrum disorder / attention deficit hyperactivity disorder / migraine headaches / cleft palate / epilepsy / bipolar disorder / /

MedicalTreatment

contraception / contraceptive method / /

Organization

EMA’s Pharmacovigilance and Risks Assessment Committee / European Medicines Agency / European Union / Medicines and Healthcare products Regulatory Agency / contact An / Pharmacovigilance Risk Assessment Committee / /

Person

Arch Dis / Monika Benstetter / /

/

Position

press officer / pharmacist / /

Product

valproic acid / carbamazepine / /

ProgrammingLanguage

EC / /

URL

www.ema.europa.eu/contact / /

SocialTag